Hexagon Nutrition Ltd
Incorporated in 1993, Hexagon Nutrition
Ltd is a research-driven nutrition company.[1]
- Market Cap ₹ 836 Cr.
- Current Price ₹ 68.0
- High / Low ₹ 78.7 / 48.0
- Stock P/E 20.0
- Book Value ₹
- Dividend Yield 0.43 %
- ROCE %
- ROE 16.4 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 52.1% CAGR over last 5 years
Cons
- Earnings include an other income of Rs.15.6 Cr.
- Working capital days have increased from 102 days to 204 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Packaged Foods
Part of Nifty IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 99 | 86 | 107 | 114 | 132 | 319 | |
| 88 | 79 | 94 | 115 | 119 | 276 | |
| Operating Profit | 10 | 7 | 13 | -1 | 13 | 43 |
| OPM % | 11% | 9% | 12% | -0.8% | 10% | 14% |
| 1 | 3 | 2 | 2 | 5 | 16 | |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 3 | 2 | 2 | 3 | 3 | 6 |
| Profit before tax | 8 | 7 | 13 | -3 | 14 | 51 |
| Tax % | 7% | 24% | 29% | 18% | 25% | 26% |
| 7 | 6 | 9 | -3 | 10 | 38 | |
| EPS in Rs | 0.67 | 0.51 | 0.81 | -0.28 | 0.95 | 3.45 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | 41% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 52% |
| 3 Years: | 273% |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 35 | 37 | 56 | 51 | 61 | 220 |
| 26 | 25 | 22 | 28 | 40 | 25 | |
| 24 | 21 | 26 | 36 | 28 | 49 | |
| Total Liabilities | 96 | 94 | 116 | 126 | 141 | 305 |
| 21 | 20 | 20 | 22 | 25 | 41 | |
| CWIP | 0 | 0 | 2 | 1 | 2 | 1 |
| Investments | 12 | 16 | 20 | 16 | 8 | 34 |
| 62 | 58 | 74 | 86 | 107 | 230 | |
| Total Assets | 96 | 94 | 116 | 126 | 141 | 305 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 10 | 5 | 1 | 7 | -2 | 8 | |
| -1 | -2 | -11 | -8 | -8 | -19 | |
| -5 | -4 | 7 | 3 | 11 | 11 | |
| Net Cash Flow | 5 | -1 | -3 | 2 | 1 | -1 |
| Free Cash Flow | 9 | 5 | -4 | 2 | -8 | 2 |
| CFO/OP | 113% | 75% | 31% | -852% | 5% | 44% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 50 | 57 | 52 | 76 | 67 | 89 |
| Inventory Days | 128 | 149 | 192 | 150 | 146 | 145 |
| Days Payable | 108 | 95 | 108 | 152 | 80 | 61 |
| Cash Conversion Cycle | 71 | 110 | 136 | 74 | 132 | 173 |
| Working Capital Days | 89 | 58 | 76 | 65 | 1 | 204 |
| ROCE % | 10% | 15% | 2% | 15% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Branded Nutrition Segment Revenue Share % of revenue |
|
||
| Capacity Utilization - Clinical Nutrition % |
|||
| Export Revenue Share (Rest of World) % of revenue |
|||
| Number of Distributors count |
|||
| Number of Permanent Employees (Consolidated) count |
|||
| Production Volume - Dry Pre-mix MT |
|||
| Production Volume - Ready-to-Use Food (RUF/RUTF) MT |
|||
| Top 10 Customer Revenue Concentration % of revenue |
|||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement regarding the Notice of 33rd Annual General Meeting and Remote-e-voting information to be held on Tuesday 22nd September 2026 through Video Conference (''''VC'''')/ …
-
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers), Regulations, 2011 And Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015.
- Promoter-Managing Director Vikram Kelkar bought 16,300 shares on 17 August 2026, raising holding to 21.12%.
-
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers), Regulations, 2011 And Regulation 7 (2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015.
- Promoter Dr. Nikhil Kelkar bought 16,400 shares on 17 August 2026, raising holding to 17.27%.
-
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers), Regulations, 2011 And Regulation 7 (2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015.
- Promoter group member Anuradha Kelkar bought 15,000 shares on 17 August 2026, raising holding to 7.38%.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Dr. Nikhil Kelkar acquired 16,400 Hexagon Nutrition shares on 17 August 2026.
Concalls
-
Aug 2026Transcript PPT REC
-
Jul 2026Transcript PPT REC
Business Profile:[1]
Hexagon Nutrition is a research-
driven nutrition company engaged
in the development, manufacturing
and marketing of nutrition products
across micronutrient premixes, branded
wellness and clinical nutrition, therapeutic formulations, ready-to-use foods (RUFs)
and micronutrient powders (MNPs).